Teams at Translational Drug Development (TD2)

Independently manages Phase I–III oncology clinical trial sites from study start-up through close-out. Conducts qualification, initiation, interim monitoring, and close-out visits; ensures compliance with protocols, GCP, ICH, FDA regulations, and clinical objectives. Develops monitoring plans, collaborates with investigators and site staff to resolve issues, and prepares monitoring reports and follow-up documentation. This is a field-based role requiring approximately 50% overnight travel.